Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amlodipine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111303006B reveals a safer, cost-effective route for amlodipine intermediates, eliminating hazardous NaH and ensuring stable supply chains for global pharma manufacturers.
Patent CN112010801B reveals a metal-free reduction method for amlodipine base, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102010361B reveals a novel etherification route for amlodipine intermediates, offering significant yield improvements and enhanced process scalability for global API manufacturers.
Patent CN104151229B details a high-yield resolution process for Levamlodipine intermediates using DMSO-d6, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Novel crystallization process ensures 100% HPLC purity. Solves filtration issues. Reliable supply chain for API intermediates and cost reduction.
Patent CN111303006A reveals a safer Swern oxidation and C-H insertion route for amlodipine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Novel one-step nucleophilic substitution method for high-purity amlodipine. Reduces impurities and manufacturing costs for reliable supply chain partners.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Patent CN107935912A details safe efficient amlodipine intermediate preparation reducing hazards and costs for pharmaceutical supply chains globally ensuring high purity standards.
Patent CN1915974A details NMP-based chiral resolution for high-purity Amlodipine. Offers significant cost reduction and supply chain reliability for API manufacturing partners.
Patent CN107935912B reveals a safer, non-NaH route for Amlodipine intermediates. Discover cost-effective manufacturing and supply chain advantages.